TRESSENY Trademark

Trademark Overview

On Wednesday, May 15, 2019, a trademark application was filed for TRESSENY with the United States Patent and Trademark Office. The USPTO has given the TRESSENY trademark a serial number of 79263065. The federal status of this trademark filing is REGISTERED as of Tuesday, December 10, 2019. This trademark is owned by Novartis AG. The TRESSENY trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery devices, namely, injection devices for pharmaceuticals, injection devices for administering drugs * excluding devices intended for the respiratory field *
tresseny

General Information

Serial Number79263065
Word MarkTRESSENY
Filing DateWednesday, May 15, 2019
Status700 - REGISTERED
Status DateTuesday, December 10, 2019
Registration Number5929559
Registration DateTuesday, December 10, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 24, 2019

Trademark Statements

Certificate of Correction for RegistrationIn the Statement, line 5, after drugs, "excluding devices intended for the respiratory field " should be inserted.
Goods and ServicesDrug delivery devices, namely, injection devices for pharmaceuticals, injection devices for administering drugs * excluding devices intended for the respiratory field *
Translation of Words in MarkThe wording "TRESSENY" has no meaning in a foreign language.

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, July 19, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, February 9, 2021LIMITATION FROM THE IB EXAMINED AND ENTERED
Tuesday, February 9, 2021CORRECTION UNDER SECTION 7 ¿ PROCESSED
Friday, April 17, 2020LIMITATION OF GOODS RECEIVED FROM IB
Friday, April 10, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 25, 2020FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 25, 2020FINAL DISPOSITION PROCESSED
Tuesday, March 10, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 10, 2019REGISTERED-PRINCIPAL REGISTER
Saturday, October 5, 2019NOTIFICATION PROCESSED BY IB
Tuesday, September 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, September 6, 2019REFUSAL PROCESSED BY IB
Wednesday, September 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 20, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, August 20, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 20, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, August 20, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, August 19, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 19, 2019REFUSAL PROCESSED BY MPU
Thursday, August 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 26, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 25, 2019NON-FINAL ACTION WRITTEN
Thursday, July 25, 2019ASSIGNED TO EXAMINER
Tuesday, July 23, 2019APPLICATION FILING RECEIPT MAILED
Friday, July 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 18, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

tresseny devices injection intended excluding respiratory field drugs pharmaceuticals delivery namely